11th Annual Clinical Trials Summit 2020

Clinical Trials Summit will brings together Researchers, Doctors, Principle Investigators, Clinical research sites, CROs, CMOs, Investors, and senior executives from Biopharma, Medical devices and Pharmaceutical industries around the globe to discuss, reflect on and develop their ideas. It offers many opportunities for professional contact and development The 11th Annual Clinical Trials Summit 2020 will provide opportunities for everyone to learn, gain insight and new skills, and also, there will be many opportunities to network and meet new peoples from industry and patient’s clinical organizations,

Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer and entry won’t be granted at the event.

Early Bird Discounted Price (Vaild till 14th April 2020) - (INR 10,000 + GST (18%) per delegate)

Standard Price (Vaild from 15th April 2020) - (INR 15,000 + GST (18%) per delegate)

For Bulk Booking of More Than 5 Delegates – Please let us know your interests.

We have more opportunities available for the event, which gives you an opportunity to speak/exhibit/Booth/Stall and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.

Current key changes and challenges for trials in India.

Challenges while growing your research development.

Discuss the various principles and methods for implementing the project life cycle at each important phase.

Setting up the best position to sustain an agile procedure for your study design

Addressing biomarker integration into a protocol while remaining agile.

Planning and managing an adaptive clinical trials – Challenges and the best practices to achieve

Discussing on the flexibility to redesign clinical trials at intermediate stage.

Current evolution of clinical trials: Addressing challenges for the future?

Discussing the major challenges with global trials —How can they be overcome?

Discussion and development of functional processes in living organisms

Provide clinical research and construct foundations for biomedical research and forms of study.

Required advancement of clinical trials and new medicines

Discussing the pharmaceutical industry's financed portion.

Discussing future – Current challenges and overview to look out for while collaborating with the CROs and Sponsorships company

Establishing an effective and quality collaboration between Sponsors and CROs and if it fails, what are the costs and negative results of a failed partnership?

Clinical studies and patients assessment

Identification of study participants and evaluation of physiological or health outcomes.

New drugs and clinical trial rules to prepare for regulatory inspection and to improve the quality and lifespan of patients

Be part of a major networking opportunity

CEO's, CTO's, CIO's, Presidents, Vice Presidents, Directors Heads & Managers of:

Clinical Research & Development

Clinical Research Services

Clinical Operations

Clinical Data Management

Clinical IT

Clinical Trials

Medical Affairs

Regulatory Affairs

Compliance

Quality control / Assurance/GCP

Clinical Study Design

Safety Surveillance

Subject Recruitment

E-Clinical Systems

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

BANOTH VENKATESWARLU, Assistant Drugs Inspector, Central Drug Standard Control Organization (CDSCO)

CHIRAG TRIVEDI, Director & Head of Clinical Study Unit, Sanofi-Aventis

REBU NINAN, Director - Strategic Marketing & Commercial Operations – Biologics, Dr. Reddy’s Laboratories

PRASANNA GANAPATHI, Associate Vice President – Global Clinical Sciences, Mylan Laboratories

SHUBHANGI DESAI, Director - Global Clinical Trial Management, Abbott (Singapore)

YASMIN SHENOY, Director-Regulatory Affairs, Sanofi-Aventis

SHREEKANT SAPATNEKAR, Director - Clinical Research, Lilavati Hospital & Research Centre

SANDESH SAWANT, Director and Head Clinical Trials, Cipla

MURTUZA BUGHEDIWALA, Associate Director – GCO, Johnson & Johnson

RAJENDRA JANI, Senior Subject Expert & Advisor, Clinical Research Consultant

MURUGANANTHAN KRISHNAN, Country Monitoring Head - Global Development Operations, Global Drug Development, Novartis

RANJIT BARSHIKAR, CEO - QbD International, United Nations Adviser, Member Editorial Board Journal of Generic Medicines, England

SRIRUPA DAS, Director - Medical Affairs, Abbott

SUTAPA BANDYOPADHYAY NEOGI, Professor, International Institute of Health Management Research (IIHMR)

ANANT PATIL, Asst Professor Department of Pharmacology, Dr DY Patil Medical College

PRATIKSHA PALAHE, Head NFB, National facility for Biopharmaceuticals

ARUN GUPTA, Head Medical Affairs & Clinical Research, Dabur Research & Development Centre

JYOTSNA PATWARDHAN, Head Development QA, Novartis

VAIBHAV SALVI, Head - Project Management and Strategic Initiatives, Clinical Study Unit, Sanofi

KARAN THAKKAR, Regional Clinical Site Lead, Pfizer

PRASHANT A. PANDYA, DGM-Global Strategic Sourcing - Scientific Affairs, Mylan Laboratories

PRANJAL BORDOLOI, Vice President – Clinical, Medical Affairs & Pharmacovigilance, Veeda Clinical Research

PRASHANT BODHE, Director, CliniSearch

SAKHARAM GARALE, Head South-East Asia Operations ACMA & Managing Partner, RENOVARE Healthcare Solutions

SUJAY KULKARNI, Business Partner/ Medical Expert, Novartis

SANDEEP JAGTAP, Assist. General Manager - Clinical R & D, Mylan Laboratories

Plus many more to join soon